Finance

Lists
099430:KOSDAQ
Bio Plus Co Ltd
â‚©3,285.00
-0.61%
(-20.00) 1D
Sep 23, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 099430...
Open
â‚©3,295
High
â‚©3,315
Low
â‚©3,265
Mkt. cap
202.49B
Avg. vol.
188.36K
Volume
82.06K
Dividend
2.13%
Quarterly dividend
â‚©17
Ex-dividend date
Dec 27, 2024
P/E ratio
24.99
52-wk high
â‚©7,060
52-wk low
â‚©3,065
EPS
â‚©131
Shares outstanding
61.64M
No. of employees
161
Open
â‚©3,295
High
â‚©3,315
Low
â‚©3,265
Mkt. cap
202.49B
Avg. vol.
188.36K
Volume
82.06K
Dividend
2.13%
Quarterly dividend
â‚©17
Ex-dividend date
Dec 27, 2024
P/E ratio
24.99
52-wk high
â‚©7,060
52-wk low
â‚©3,065
EPS
â‚©131
Shares outstanding
61.64M
No. of employees
161
About Bio Plus Co Ltd
CEOHyun Kyu Jung
Employees161
Founded2003
Headquarters-
SectorMedical device
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
24.06B
23.18B
26.51B
25.40B
Cost of goods sold
6.52B
8.32B
8.37B
8.01B
Cost of revenue
6.52B
8.32B
8.37B
8.01B
Research and development expenses
800.51M
958.40M
870.22M
990.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.72B
10.27B
10.33B
9.69B
Operating expense
12.66B
13.91B
12.49B
11.14B
Total operating expenses
19.18B
22.24B
20.85B
19.15B
Operating income
4.88B
947.62M
5.65B
6.25B
Other non operating income
49.56M
-1.08B
278.22M
-1.46B
EBT including unusual items
5.53B
402.04M
7.22B
4.34B
EBT excluding unusual items
5.49B
397.31M
6.69B
5.15B
Income tax expense
1.12B
-3.24B
-775.92M
592.98M
Effective tax rate
20.30%
-805.10%
-10.74%
13.67%
Other operating expenses
436.96M
48.25M
253.36M
71.56M
Net income
3.12B
2.00B
6.69B
2.03B
Net profit margin
12.97%
8.64%
25.23%
8.01%
Earnings per share
-
-
-
-
Interest and investment income
51.68M
186.85M
158.68M
173.05M
Interest expense
-72.70M
-82.57M
-74.73M
-71.91M
Net interest expenses
-21.02M
104.27M
83.95M
101.14M
Depreciation and amortization charges
521.51M
204.13M
461.92M
522.23M
EBITDA
6.03B
1.83B
6.86B
7.52B
Gain or loss from assets sale
-9.00K
35.54M
-
538.64K
AI content may include mistakes. Learn more
Google apps